In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Amersham Biosciences

Division of General Electric Co.

Latest From Amersham Biosciences

A Bright Future For Optical Imaging

One bright spot emerging in this otherwise lackluster economy is the market for optical imaging technologies. Optical imaging encompasses a wide array of current and emerging techniques that use light as the primary imaging modality to characterize local anatomy down to cellular and molecular levels.

Medical Device Europe

LaserGen Inc.

LaserGen is developing a proprietary set of designer nucleotides, synthetic versions of the building blocks of DNA, which can be more easily manipulated to enhance the speed and readout quality of high-throughput sequencing.
Strategy Business Strategies

Recent Dealmaking (01/2004)

Summarizing the month in European dealmaking.

Recent Dealmaking (04/2003)

Summarizing the month in European dealmaking.
See All

Company Information